Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Jia Liu, Ranyi Luo, Yinhao Zhang, Xiaojiaoyang Li

Clin Mol Hepatol. 2024;30(4):585-619. Published online July 1, 2024

DOI: https://doi.org/10.3350/cmh.2024.0222

View: 3602 Download: 324 Web of Science: 5 Crossref: 6

Koji Hashimoto

Clin Mol Hepatol. 2020;26(4):401-410. Published online July 10, 2020

DOI: https://doi.org/10.3350/cmh.2020.0072

View: 7795 Download: 178 Web of Science: 11 Crossref: 14

Ki Youl Seo, M.D., Il-Hwan Moon, M.D., Kwon Yoo, M.D., Hye Kyung Jung, M.D., Ku Yong Chung, M.D.*, and Kum Ja Choi, M.D.*

Clin Mol Hepatol. 2001;7(4):475-484. Published online January 1, 1970

View: 2364 Download: 17

1 |

Viewed By 8731	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7553	MAFLD: How is it different from NAFLD?
Viewed By 5452	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 5057	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4580	Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease

Cited By 322	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 292	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 203	MAFLD: How is it different from NAFLD?
Cited By 101	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 92	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search